ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
XFOR holding history
X4 Pharmaceuticals, Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XFOR overviewAll 13F holders of XFORFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,588
- Value
- $49.4K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,588 | $49.4K | <0.1% | +10,588 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −1,231−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2025 | 36,941 | $8.73K | <0.1% | −10,384−21.9% | Reduced | Holders |
| Q4 2024 | 47,325 | $34.7K | <0.1% | −16,181−25.5% | Reduced | Holders |
| Q3 2024 | 63,506 | $42.5K | <0.1% | +46,727+278.5% | Added | Holders |
| Q2 2024 | 16,779 | $9.73K | <0.1% | −5,728−25.4% | Reduced | Holders |
| Q1 2024 | 22,507 | $31.3K | <0.1% | +2,129+10.4% | Added | Holders |
| Q4 2023 | 20,378 | $17.1K | <0.1% | +4,383+27.4% | Added | Holders |
| Q3 2023 | 15,995 | $17.4K | <0.1% | −18−0.1% | Reduced | Holders |
| Q2 2023 | 16,013 | $31.1K | <0.1% | +16,013 | New | Holders |